Chevron Slashes Spending Plans as Coronavirus Hammers Oil Demand

Chevron said it would cut its annual capital spending budget by 26% next year and sharply through the middle of the decade, as the coronavirus pandemic forces an industrywide reappraisal of fossil-fuel investment.

 
Airline Cards Lose Luster as Coronavirus Persists

People don't need flight upgrades, airport lounges and other perks of airline cards in a pandemic. Airlines and banks are scrambling to keep the cards at the top of customers' wallets.

 
U.S. Tech Giants Face Tighter Regulation in Europe

The European Union plans to introduce in coming weeks new proposals aimed at changing behavior-and in some cases, business models-at large online platforms, reasserting the bloc's role as global tech cop.

 
Vaccine No Silver Bullet for European Airlines

The sector can finally look forward to recovery, but erasing the damage caused by the pandemic will take years

 
Etsy Can Stay Healthy Without Masks

Its platform design could help the company stay in the limelight once the Covid-19 pandemic subsides.

 
Sorry, Millennials. Over-40s Are In at Gucci.

The Italian fashion house has toned down its eclectic, pop-culture-infused designs to court older, wealthier shoppers.

 
Venture Capitalists Back Biotech Push to Combat Aging

Khosla Ventures is leading a $12 million seed financing for Rubedo Life Sciences Inc., while Andreessen Horowitz and entrepreneur Elad Gil are leading a $90 million investment in BioAge Labs Inc. These follow the disclosure last week by startup Elevian Inc. of a $15 million seed funding led by Prime Movers Lab.

 
California Company's Cell-Grown Chicken Gets Nod From Singapore

Eat Just, a California-based food company, won regulatory approval in Singapore to sell chicken grown from poultry cells, a step forward for a nascent technology that aims to revolutionize meat production.

 
Many Companies Turn 401(k) Matches Back On

More companies that cut the contributions they made to employees' 401(k) retirement plans earlier this year are reversing course as their businesses rebound and a Covid-19 vaccine is on the horizon.

 
Covid-19 Vaccine Contest Isn't Over

Pfizer and Moderna might be first with vaccines, but others could still grab market share.

(END) Dow Jones Newswires

December 03, 2020 09:15 ET (14:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.